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Background: Interventions providing foods fortified with multiple micronutrients can be a cost-effective and
sustainable strategy to improve micronutrient status and physical growth of school children. We evaluated the
effect of micronutrient-fortified yoghurt on the biochemical status of important micronutrients (iron, zinc, iodine,
vitamin A) as well as growth indicators among school children in Bogra district of Bangladesh.
Methods: In a double-masked randomized controlled trial (RCT) conducted in 4 primary schools, 1010 children
from classes 1–4 (age 6–9 years) were randomly allocated to receive either micronutrient fortified yoghurt
(FY, n = 501) or non-fortified yoghurt (NFY, n = 509). For one year, children were fed with 60 g yoghurt everyday
providing 30% RDA for iron, zinc, iodine and vitamin A. Anthropometric measurements and blood/urine samples
were collected at base-, mid- and end-line. All children (FY, n = 278, NFY, n = 293) consenting for the end-line blood
sample were included in the present analyses.
Results: Both groups were comparable at baseline for socio-economic status variables, micronutrient status markers
and anthropometry measures. Compliance was similar in both the groups. At baseline 53.4% of the population was
anemic; 2.1% was iron deficient (ferritin <15.0 μg/L and TfR > 8.3 mg/L). Children in the FY group showed improvement
in Hb (mean difference: 1.5; 95% CI: 0.4-2.5; p = 0.006) as compared to NFY group. Retinol binding protein (mean diff:
0.05; 95% CI: 0.002-0.09; p = 0.04) and iodine levels (mean difference: 39.87; 95% CI: 20.39-59.35; p < 0.001) decreased
between base and end-line but the decrease was significantly less in the FY group. Compared to NFY, the FY group
had better height gain velocity (mean diff: 0.32; 95% CI: 0.05-0.60; p = 0.02) and height-for-age z-scores (mean diff: 0.18;
95% CI: 0.02-0.33; p = 0.03). There was no difference in weight gain velocity, weight-for-age z-scores or Body Mass Index
z-scores.
Conclusion: In the absence of iron deficiency at baseline the impact on iron status would not be expected to be
observed and hence cannot be evaluated. Improved Hb concentrations in the absence of a change in iron status
suggest improved utilization of iron possibly due to vitamin A and zinc availability. Fortification improved height gain
without affecting weight gain.
Trial registration: ClinicalTrial.gov: NCT00980733
Keywords: Micronutrient fortification, Retinol binding protein, Iodine, Bangladesh, Zinc* Correspondence: ssazawal@jhsph.edu
1Department of International Health, Johns Hopkins Bloomberg School of
Public Health, Baltimore, MD, USA
Full list of author information is available at the end of the article
© 2013 Sazawal et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Sazawal et al. BMC Public Health 2013, 13:514 Page 2 of 11
http://www.biomedcentral.com/1471-2458/13/514Background
Micronutrient malnutrition especially of iron, zinc, vita-
min A and iodine is recognized as an important public
health problem affecting more than 2 billion people
worldwide [1]. Left untreated, even sub-clinical micronu-
trient malnutrition has significant negative consequences
on health and economic development. As many as a third
of the world’s population do not meet their physical and
intellectual potential because of clinical and sub-clinical
vitamin and mineral deficiencies [2]. Concern for micro-
nutrient deficiency is particularly high among children as
there is an increased nutritional demand among them due
to growth spurts and high physical activity. The full gen-
etic potential of the child for physical growth and mental
development may be compromised due to sub clinical de-
ficiencies of micronutrients, making them more vulnerable
to develop frequent and more severe common day-to-day
infections thus triggering a vicious cycle of under nutrition
and recurrent infections [3-5]. Almost two-thirds of the
deaths of children around the world are directly or indir-
ectly associated with nutritional deficiencies [6].
Rural Bangladeshi populations, particularly children, are
also at high risk of micronutrient deficiencies particularly
vitamin A, iron, iodine and zinc, due to the consumption
of a predominantly rice-based diet with few animal-source
foods, iodine/zinc deficient soil [7], lack of access to safe
drinking water, inadequate or nonexistent sanitation facil-
ities and presence of infectious diseases and/or parasitic
infection [8]. In Bangladesh, approximately 40 percent of
children (6–15 years aged) have anemia with 6.9 percent
of them having iron deficiency [9]. Thirty four percent of
Bangladeshi children are iodine deficient with another
21.7 percent suffer from vitamin A deficiency [10]. A sur-
vey conducted in 2004–2005 showed that the prevalence
of goiter among children 6 to 12 years old was 6.2% [11].
Supplementation based programs had limited success
for iron deficiency, therefore in order to alleviate micronu-
trient deficiencies, WHO has recognized that future strat-
egies should focus on identifying methods to deliver
essential micronutrients such as iron, zinc, vitamin A, and
iodine using suitable food vehicles [12]. There is increas-
ing body of evidence suggesting micronutrient interven-
tions might benefit the health and development of school
age children and that multiple micronutrients might be
more effective than single micronutrient. Fortifying foods
with essential micronutrients is, thus a practical and cost
effective strategy to improve nutrition status [13]. This has
also been shown by a systematic review [5] for impact of
fortification on improvement in micronutrient status and
reduction in anemia among school children.
It is well recognized that given varied food preferences
and consumption, multiple vehicles will need to be used
in a practical community setup. Typically, locally produced
and commonly consumed foods are the best candidates. InBangladesh, yoghurt is a readily available and consumed
food. Based on this premise, Grameen in Bangladesh in col-
laboration with social responsibility division of Dannon
established non-profit social sector factory to produce yog-
hurt at low cost for local consumption in Bogra, Bangladesh.
Global Alliance for Improved Nutrition (GAIN) used this
opportunity to utilize locally produced yoghurt as a vehicle
for delivery of 4 important micronutrients and thus the test
intervention of this trial with 30% RDA of iron, zinc, vitamin
A and iodine was developed.
In order to evaluate the efficacy of this intervention,
we undertook a community-based, doubled-masked ran-
domized trial in Bogra district, wherein children (aged
6–9 years) fed with micronutrient fortified yoghurt (30%
RDA of iron, zinc, vitamin A and iodine) were compared
to children fed with non-fortified yoghurt for one year
on micronutrient status indicators (iron, zinc, vitamin A
and iodine) and physical growth. This was based on the
hypothesis that consumption of micronutrient fortified
yoghurt by the school children over a period of one year
would have a positive impact on their micronutrient sta-
tus markers and physical growth indicators.
Methods
Study population and setting
The study was conducted between June 2008 and March
2010 in primary schools of Gabtali town of Bogra district
in the Rajshahi Division, Northern Bangladesh. We se-
lected schools in Gabtali town because of its close proxim-
ity to a yoghurt factory. Six primary schools from Bogra
district were selected for the study. Of these 2 schools
were assigned as pure control (no yoghurt was provided
to the children and data from these two schools have not
been used in the present analysis). The remaining four pri-
mary schools were randomly selected as yoghurt schools
(fortified yoghurt and non fortified yoghurt). The study
area had similar geographical characteristics to the rest of
the plain lands in Bangladesh, including high population
density, fertile agricultural land, low risk of malaria and
minimal hookworm infection [14].
Ethics
The human research and ethical review committees at the
Johns Hopkins University, USA, Shaheed Zia-ur Rahman
Medical College, Bangladesh and National Research
Council of Bangladesh approved the study protocol.
Sample size
Pretrial sample size estimation (based on assumptions
from previous data), 400 children were planned to be
enrolled and this sample size was estimated to, with an
alpha of 0.05 and power of 90%, provide ability to detect
a change in height by 2.56 cm and weight by 930 g over
the baseline weight and height measurements; detect a
Table 1 Composition of fortified yogurt provided to the
study participants*
Nutritional composition Per 60 g % RDA
Energy (Kcal) 71.6 -
Protein (g) 2.3 -
Lipids (g) 2.5 -
Carbohydrates (g) 10.1 -
Of which sugars (g) 3.8 -
Calcium (mg) 85 18.4%
Phosphorus (mg) 67 18.7%
Iron (mg) 3.3 30.0%
Zinc (mg) 3.0 30.0%
Iodine (μg) 40 30.0%
Vitamin A (μg) 140 30.0%
*In addition contains: Whole milk, Date molasse, Sugar starch, Aspartame,
Acesulfam K, Danone Yogurt culture, micronutrient premix.
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the baseline Hb; detect reduction in iron deficiency
anemia by 38% and zinc deficiency by 37%. The sample
size was provided for 5% attrition. However, due to prac-
tical reasons we had to enroll every child in class in yog-
hurt groups, for which we amended the protocol and
thereby enrolled 500 children per group. This worked
well as the attrition due to refusal for blood sampling
was also higher than anticipated 5%.
Consent and enrollment
Before the start of the study, the purpose and details of the
study was explained in a meeting to all concerned parents
and school officials. The possible risks and benefits associ-
ated were read out and explained to the parents in their
local language, and informed written consent sought from
the parents of each of the selected children prior to the en-
rollment in the study. For practical reasons, all the children
of the class 1–4 were invited to take part in the study. The
inclusion criteria for enrollment into the study was chil-
dren aged 6 to 9 years attending selected schools, who
were likely to remain in the same school and parents pro-
viding consent. Children with severe malnutrition needing
nutritional rehabilitation or chronic/severe illness requiring
hospitalization or special treatment were excluded and re-
ferred for treatment. After obtaining consent from parents
and assent from children, children were enrolled and
scheduled to visit clinics for baseline assessments.
Masking and randomization
Children were randomized by their enrollment serial
number into either the micronutrient fortified yoghurt
(FY) group or non-fortified yoghurt (NFY) group that
would receive identical yoghurt with no added
micronutrients. Using in-house computer software, a ran-
dom sequence of group codes with a permuted block
length of 6 was generated to randomly allocate the indi-
vidual child to one of the two yoghurt groups (NFY group
or FY group). Group codes from 1 to 6 were used to iden-
tify the fortified and non-fortified yoghurt. The codes of
the groups were not known to the investigators, field
team, teachers, children or anyone involved in the study
during the field implementation. Cups were prepared and
labeled with group codes a day in advance at a factory in
Bogra. The yoghurt for the two intervention groups was
identical in packaging, appearance, taste and smell. Chil-
dren in both the groups were followed up for 12 months.
Yoghurt distribution and follow-up
Every day in the morning, the yoghurt cups were col-
lected from the factory and the delivery containers were
insulated with ice packs to maintain the temperature
and quality of the yoghurt during transportation and de-
livery. The yoghurt delivery team distributed the yoghurtin the class by code allocated to the child during
randomization. The assistant verified the child’s identity
(e.g. child’s name, name of father and mother). Children
allocated to the yoghurt groups received one cup of the
yoghurt (60 g) daily during the lunch break of the school
for one year. The feeding session was strictly monitored
and supervised by the field workers and class teachers
and the compliance to the intervention was recorded in
compliance record forms. A separate list was prepared
for children who were absent from school and their re-
spective yoghurt cups were delivered at home in the
afternoon. In case of absenteeism due to sickness, mor-
bidity information of the child was recorded in a data
record sheet. During holidays, yoghurt was distributed at
pre-scheduled points near the child’s home.
Children were informed beforehand about their re-
spective delivery points. For children who did not turn
up at these locations, yoghurt was taken to their homes.
The detailed composition of fortified yoghurt is
presented in Table 1.Data collection
Socio-demographic assessments
Data concerning socio-economic status (SES) was col-
lected at baseline only. During the survey, parents or
caregivers were interviewed about socio-demographic
characteristics of the children (age, sex, illness history
and medical supplements) and mothers (age, education,
family size, and household SES) using standardized
questionnaires by trained field workers.Blood/urine sample collection and anthropometric
measurements
Anthropometric data and blood/urine samples were col-
lected at base- mid- and the end-line from all children
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at base-, mid- and end-line, clinics were established to
carry out a medical examination, collect blood/ urine
samples and measure the height and weight of children.
A unique bar-coded ID for each child was used and a
clinic kit specific for that child was issued after verifying the
child’s identity. A non-fasting venous blood sample (~5
mL) was drawn by a trained technician using trace
element-free syringes. From this sample, 2 mL of blood was
immediately transferred into an ethylenediaminetetraacetic
acid (EDTA) vial to obtain a detailed hemogram and the
rest was centrifuged at 4000 rpm for 20 minutes. Plasma
was separated within 15 minutes of blood collection, and
aliquots were transferred into 2 trace element-free micro-
centrifuge tubes and stored at −20°C for further micronu-
trient analysis. For all blood sample collection procedures,
trace element-free tubes and pipettes were used and sam-
ples were protected against sunlight. Casual urine samples
were collected in 10 mL capped polypropylene tubes and
stored at −20°C for later urinary iodine analysis. Plasma
samples were analyzed for markers of iron (transferrin re-
ceptors (TfR) and ferritin), retinol binding protein (RBP),
zinc status and acute phase proteins: C-reactive protein
(CRP) and α-1 acid glycoprotein (AGP).
Weight was measured to the nearest 10 g using an
electronic scale (Kantewala, Delhi, India) by two inde-
pendent observers while the children were wearing their
school uniforms. The scale was checked for accuracy
with standard weights after about every 25 measures.
Height was measured to the nearest 0.1 cm without
shoes using non-stretchable microtoise tape posted flat
against a wall.
Laboratory analysis of blood and urine samples
A small aliquot of blood was analyzed on an automated
hematology analyzer (Sysmex XT-1800i analyzer, Japan)
with WBC 5-part differential at the Popular Diagnostic
Center Limited, Bogra, Bangladesh on the same day as
the blood was collected. Routine hematology controls
were used for quality control (Sysmex hematology con-
trols, Japan). Double sandwich ELISA was used to
analyze plasma ferritin, TfR, vitamin A (RBP), CRP and
AGP markers at DBS-Tech, Willstaett, Germany [15].
Plasma zinc estimations were performed by standard
methods using an atomic absorption spectrometer (AAS
800-Perkin Elmer) at the laboratory facility of the Center
for Micronutrient Research, Annamalai, India [16]. The
urinary samples were processed for estimation of urinary
iodine using the modified Sandell-Kolthoff microplate
method [17] at the WHO reference laboratory at the All
India Institute of Medical Sciences (AIIMS), New Delhi.
Assay precision was evaluated on repeated analysis of
pooled plasma and urine samples. Ten percent of sam-
ples of each parameter were measured in duplicate. Thewithin-assay variability of plasma ferritin, TfR, RBP, CRP,
AGP, zinc, and urinary iodine was <6% and between-
assay variability was < 10%.
Definitions
Anemia was defined as Hb concentration < =115.0 g/L
for children aged 6–9 years old [18]. Plasma ferritin con-
centrations <15 μg/L was defined as depleted iron stores
[18]. Iron deficiency anemia (IDA) was defined as
Hb < 115.0 g/L and plasma ferritin <15 μg/L [18].
Plasma TfR concentration >8.3 mg/L was considered an
indication of tissue iron deficiency [19]. Body iron was
calculated using the equation: body iron (mg/kg) = − [log
(TfR/ferritin ratio) -2.8229]/0.1207 [20].
Vitamin A deficiency was defined as plasma RBP con-
centrations <0.70 μmol/L [21]. Zinc deficiency was defined
as plasma zinc concentration <9.945 μmol/L for blood
samples taken from non-fasting subjects [16,22]. Low
urinary iodine excretion (UIE) was defined as urinary iod-
ine concentration <100 μg/L [18]. A plasma concentration
of CRP (>5 mg/L) and/ or AGP (>1g/L) was considered an
indication of an acute phase response [15].
Statistical analyses
Visual basic and Oracle 8i was used for data entry and
management. Data were entered daily and checked consist-
ently for errors. The analyses were performed in STATA
10.0 (Stata Corp., College Station, Texas, USA). Anthropo-
metric Z-scores were calculated using WHO standards
[23]. Intent-to-treat analysis was performed and all chil-
dren (FY-group 278, NFY-group 293) consenting for the
end-study blood sample were included in analyses. For the
primary analysis the authors used alphabetical codes for
the groups as they were still blinded to the real group iden-
tity. The groups were assessed for comparability at base-
line. The statistical significance for the group differences of
continuous variables was established using a Student’s
t-test, and of categorical variables by chi-square test. Sig-
nificance was considered as P-values ≤0.05. Paired t-test
was used to determine if there were significant mean differ-
ences in the markers for micronutrient status and growth
parameters within each group before and after intervention
and 95% CI were calculated for these differences. Further,
paired analysis was performed to compare the change in
status of micronutrient markers at baseline and end study
between two groups. For the growth analysis corrected for
baseline, regression models were fitted with the end study
measurements as the dependent variable, group allocation
and baseline measurement as the independent variable.
Results
Participants
Figure 1 shows the trial profile. Of the 1063 eligible chil-
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Figure 1 Trial profile.
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either micronutrient-fortified yoghurt (FY group; n = 501)
or the same yoghurt without added micronutrients (NFY
group; n = 509). The dropout rate (18% at mid study and
22% at end study) was similar between the study groups,
and the main reasons for dropout were refused blood sam-
pling, relocation out of the study area, change of school
and a very small proportion of children who did not like
yoghurt (Figure 1). Baseline data available for the subjects
who were lost to follow up did not differ from data for
those included in the present analysis (data not shown).
Baseline data
The baseline profile of the study participants by inter-
vention group is shown in Tables 2 and 3. Both thefortified and non-fortified groups were comparable for
socio-economic variables (Table 2), micronutrient status
and anthropometry (Table 3) at baseline. The mean age
of the participants was 7.0 ± 0.5 years and 52.4% were
girls. The mean Hb level was 114.7 g/L while mean red
cell distribution width was 14.4% (Table 3). The total
prevalence of anemia was 53.4% (Hb < =115.0 g/L) and
was not significantly different between boys and girls
(Chi-square test, P > 0.05). At baseline 2.1% children
were iron deficient (ferritin <15.0 μg/L and TfR > 8.3
mg/L) and this was not affected, even if the children
with infection were removed from the analysis. The
mean concentration of serum retinol binding protein
(RBP) was 1.24 ± 0.29 μmol/L. Children with RBP con-
centration <0.7 μmol/L (vitamin A deficiency) and
Table 2 Baseline comparison for SES and other variables
among two groups
Fortified yoghurt Non fortified yoghurt
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All values are in percentages unless specified.
Table 3 Baseline comparisons for blood and growth
parameters between fortified and non-fortified yoghurt
groups
Variables Fortified
yoghurt (n = 278)
Non-fortified
yoghurt (n = 293)
Mean ± SD Mean ± SD
Growth parameters weight (kg) 21.94 ± 4.72 21.39 ± 4.52
Height (cm) 124.0 ± 9.09 122.8 ± 8.90
WAZ −1.68 ± 1.32 −1.82 ± 1.42
< −2.0 (n, %) 114 (41.6) 125 (42.7)
HAZ −1.01 ± 1.20 −1.17 ± 1.17
<−2.0 (n, %) 57 (20.8) 69 (23.5)
BMIZ −1.59 ± 1.25 −1.80 ± 3.28
<−2.0 (n, %) 92 (33.6) 86 (29.4)
Iron status markers hemoglobin(g/L) 114.7 ± 8.6 114.7 ± 8.8
Red cell width (%) 14.39 ± 2.77 14.26 ± 2.27
Serum Ferritin (μg/L) 68.28 ± 35.99 70.03 ± 39.25
Serum Transferrin receptor (mg/L) 5.69 ± 1.17 5.79 ± 1.21
Body Iron Store (mg/Kg Bodywt) 7.03 ± 2.23 6.99 ± 2.25
Retinol binding Protein (μmol/L) 1.25 ± 0.30 1.22 ± 0.27
Zinc (μmol/L) 9.11 ± 3.30 9.22 ± 3.65
Iodine (μg/L) 160.71 ± 93.12 182.42 ± 102.96
Infection defined as
CRP(>5 mg/L) (incubation) (n, %) 8 (2.7) 6 (2.0)
AGP (>1 g/dL) (Convalescence) (n, %) 26 (9.4) 33 (11.3)
AGP (>1 g/dL) and/or CRP (>5 mg/L) 29 (10.4) 33 (11.3)
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ciency) was 1.1% and 23.6%, respectively. The mean
urinary iodine level was 171.6 μg/dL and the proportion
of children <100 μg/dL was 27.6%. The zinc status was
less than optimal; the mean plasma zinc concentration
was 9.17 μmol/L and 70% children had zinc levels
<9.945 μmol/L. The concentrations of plasma ferritin
and RBP of those school children with elevated acute
phase proteins (CRP > 5 mg/L and/or AGP >1 g/L) com-
pared to those with normal concentrations at the time ofthe baseline blood sampling were different. Those in the
fortified yoghurt and non-fortified yoghurt group had sig-
nificantly higher ferritin concentrations (p = 0.006 and
0.02 respectively) and significantly lower RBP concentra-
tions (p = 0.13 and p = 0.00, respectively) when the acute
phase proteins were elevated (Additional file 1: Table S5).
Other blood parameters were not affected by the presence
of elevated acute phase proteins. However the results in
the subgroup with no inflammation (89.1% of the sample)
were not different from overall results. The prevalence of
stunting, underweight and BMIZ scores - < 2 Z were
22.2%, 42.2% and 31.4% respectively. None of these preva-
lence were significantly different between boys and girls
(Chi-square test, P > 0.05).Compliance
As the feeding sessions were monitored, the compliance
(adherence to intervention) was assessed by collecting
information on consumption and recording the
remaining quantity of yoghurt (not consumed by the
children) during the one-year intervention period. The
compliance of the children for intervention in both the
groups was ~97.0 percent and was similar in both
groups.
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deficiency prevalence
Consumption of fortified yoghurt did not affect the iron
status indicators and body iron stores. However, children in
the FY-group showed improvement in Hb levels (0.8 g/L;
mean difference: 1.5; 95% CI: 0.4-2.5; p = 0.006) compared
to NFY-group (Table 4). Although concentrations of both
RBP and iodine went down from baseline, compared to
the NFY group, the RBP and iodine concentrations were
significantly better in the children receiving fortified yo-
ghurt, with estimated effect sizes of 0.05 μmol/L (p = 0.04)
and 39.87 μg/dL (p = <0.001) respectively (Table 4). Severe-
iodine deficiency was present in only 5.1 percent of chil-
dren. Zinc status improved in the fortified group but the
difference in mean zinc levels between the two groups was
not statistically significant. Although mean zinc concentra-
tions improved, they were still below the accepted cutoff
for the age group at end-line (9.94 μmol/L). Furthermore,
consumption of micronutrient fortified yoghurt reduced
the worsening of vitamin A and iodine status that was
observed in control group there by showing a significant
difference in RBP levels and urinary iodine excretion. The
concentrations of plasma ferritin and RBP of those school
children with elevated acute phase proteins (CRP > 5 mg/L
and/or AGP >1 g/L) compared to those with normal con-
centrations at the time of the end-line blood sampling
were different (Fortified Yoghurt p = 0.00; p = 0.001 Non
Fortified Yoghurt p = 0.04; p = 0.001) (Additional file 1:
Table S6). Other blood parameters were not affected by
the presence of elevated acute phase proteins. However
the results in the subgroup with no inflammation
(89.3% of the sample) were not different from overall
results suggesting that inflammation did not contribute
to observed results for ferritin and RBP.
Effect on physical growth
Compared to NFY-group, children in FY-group had bet-
ter height gain velocity (5.46 cm/yr, mean difference:Table 4 Paired comparison for blood parameters between base
yoghurt groups
Variable Fortified yoghurt
(n = 278) Mean ± SD
Non-fortified yogh
(n = 293) Mean ± S
Hb (g/L) 0.8 ± 0.61 −0.6 ± 0.66
Ferritin (μg/L) −0.49 ± 31.75 1.56 ± 27.35
sTfR (mg/L) −0.008 ± 0.74 −0.02 ± 0.75
Body Iron Store −0.01 ± 1.53 0.08 ± 1.42
(mg/Kg B wt)
RBP (μmol/L) −0.01 ± 0.29 −0.06 ± 0.25
Zinc (μmol/L) 1.44 ± 4.37 1.24 ± 4.01
Iodine (μg/L) −42.6 ± 130.0 −82.5 ± 121.9
*Mean difference was calculated using paired analysis.0.32; 95% CI: 0.05-0.60;p = 0.02) and height-for-age z-
scores (HAZ) (mean difference: 0.18; 95% CI: 0.02-0.33;
p = 0.03). There was no difference in weight gain vel-
ocity, WAZ or BMIZ scores (Table 5). After correcting
for baseline measurements, children in the FY group still
had significantly better HAZ and height gain velocity
than those in the NFY (Table 6).
Discussion
The study was designed to investigate whether regular
consumption of micronutrient fortified yoghurt (deliver-
ing 30% RDA of zinc, iron, iodine and vitamin A) over a
period of 1 year could improve the micronutrient status
and physical growth of school children. To our know-
ledge, this is one of the first reports of a study that used
yoghurt as a vehicle for delivery of micronutrients and
evaluated the impact among school children in a
double-blind RCT. Although consumption of fortified
yoghurt did not result in improvement in iron status in-
dicators, it did show a significant improvement in Hb,
and an impact of iodine status indicated by significantly
lower decline urinary iodine levels when compared to
the NFY group. One year of fortification resulted in
an improvement in linear growth with a statistically
significant change in height velocity and HAZ. A sys-
tematic review [5], evaluated the effect of the multi-
micronutrient (MMN) fortification of foods compared to
unfortified foods on the micronutrient status of school
children and measured a statistically significant improve-
ment in micronutrient status in the intervention group
compared to the control group, taking baseline values
into account. Some studies have reported positive effects
on growth but the overall effects on these outcomes are
equivocal [5]. The response to fortification in the present
study showed an improvement in Hb concentrations,
even though no iron deficiency was present at baseline,
and although RBP and iodine concentrations fell in both
groups, they were significantly higher in the FY groups.line and end study comparing fortified and non-fortified
urt
D
Mean Diff* 95% CI P value
Lower Upper
1.5 0.4 2.5 0.006
−2.05 −6.91 2.82 0.41
0.01 −0.11 0.14 0.86
−0.09 −0.33 0.15 0.46
0.05 0.002 0.09 0.04
0.20 −0.57 0.98 0.61
39.87 20.39 59.35 0.001
Table 5 End study comparisons for growth parameters between fortified and non-fortified yoghurt groups
Fortified yoghurt
(n = 274) Mean ± SD
Non-fortified yoghurt
(n = 293) Mean ± SD
Mean Diff*/
Odds ratio
95% CI P value
Lower Upper
Weight velocity (kg/yr) 3.04 ± 1.73 3.06 ± 1.41 −0.02 −0.29 0.23 0.84
Height velocity (cm/yr) 5.46 ± 2.00 5.14 ± 1.24 0.32 0.05 0.60 0.02
WAZ −1.51 ± 1.20 −1.54 ± 1.21 0.03 −0.14 0.20 0.68
<−2 (n, %) 93 (33.9) 96 (32.8) 0.77 1.05 0.74 1.50
HAZ −1.00 ± 1.12 −1.17 ± 1.15 0.18 0.02 0.33 0.03
<−2 (n, %) 49 (17.9) 68 (23.2) 0.72 0.48 1.09 0.12
BMIZ −1.28 ± 1.24 −1.17 ± 1.08 −0.10 −0.29 0.09 0.29
<−2 (n, %) 66 (24.1) 61 (20.8) 1.21 0.81 1.79 0.35
*Mean difference was calculated using paired analysis.
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http://www.biomedcentral.com/1471-2458/13/514A decline in the intervention group may be suggesting
30% RDA of selected micronutrients in the fortified yog-
hurt may not have been adequate to reverse decline in
vitamin A and iodine concentrations in this population
of school children.
In the present study, iron deficiency was not observed
i.e. ferritin, TfR and estimated body iron stores were in
normal range. Consistent with our finding, Winichagoon
et al. [13] did not find an effect on iron status indicators
after adding 5 g of elemental iron via multi-
micronutrient (MMN) powder to the school lunches of
Thai children. It has been demonstrated that the max-
imal inhibitory effect of calcium on iron absorption is
reached at a level of ~300 mg of calcium [24]. The possi-
bility of the calcium content having been responsible for
lack of effect on iron status markers is very unlikely as
the calcium content of yoghurt was less than 100 mg.
However cannot be totally ruled out given the study de-
sign and fairly adequate iron status of the population
and therefore a possibility of reduced absorption and po-
tential for minor impact.
In this study, the prevalence of elevated plasma CRP
and AGP was low; indicating the presence of ongoing orTable 6 Comparison for growth parameters between fortified
for baseline measurements
Fortified yoghurt
(n = 274) Mean ± SD
Non-fortified yo
(n = 293) Mean
Weight velocity (kg/yr) 3.04 ± 1.73 3.06 ± 1.41
Height velocity (cm/yr) 5.46 ± 2.00 5.14 ± 1.24
WAZ 0.22 ± 0.70 0.29 ± 0.77
<−2 (n, %) 93 (33.9) 96 (32.8)
HAZ 0.05 ± 0.40 0.008 ± 0.2
<−2 (n, %) 49 (17.9) 68 (23.2)
BMIZ 0.32 ± 0.88 0.63 ± 3.05
<−2 (n, %) 66 (24.1) 61 (20.8)
*Mean difference was calculated using paired analysis.recent acute inflammation in the study population was
low, however that may not rule out some chronic infec-
tions but then their presence would have caused anemia
rather than contrary. Prevalence of hemoglobinopathy,
another possible cause for high ferritin concentrations in
the presence of anemia, needs consideration. Anemia
was present in a little more than half of the children in
both the groups at baseline with a mean Hb concentra-
tion of 114.7 g/L. But levels of Hb in this population and
distribution of Hb do not favor hemoglobinopathy as a
cause of high ferritin. In fact in population with much
higher levels of anemia in Delhi contribution of
hemoglobinopathy to levels of ferritin has not been dem-
onstrated (Unpublished-data). There was a significant
difference in Hb levels of 1.5 g/L between FY and NFY
groups after one year of fortification. A similar effect on
Hb status was recently reported among Kenyan subjects
with HIV infection in whom MMN supplementation
resulted in increased Hb concentrations only among
those without signs of inflammation [25]. Although
there are studies which found significant effects of mul-
tiple micronutrient fortification on concentrations of





95% CI P value
Lower Upper
−0.02 −0.29 −0.23 0.84
0.32 0.05 0.60 0.02
−0.04 −0.14 0.07 0.50
1.22 0.72 2.06 0.47
4 0.06 0.005 0.11 0.03
0.51 0.23 1.12 0.09
−0.14 −0.32 0.03 0.11
1.21 0.81 1.79 0.35
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http://www.biomedcentral.com/1471-2458/13/514present study, the difference in Hb between the FY and
NFY groups, despite the lack of difference in the iron sta-
tus markers suggest better utilization of iron, which may
have been caused by bio-available zinc and vitamin A.
Vitamin A supplementation has been shown to increase
erythropoietin (EPO) [27]. Retinoic acid, a vitamin A me-
tabolite, has been reported to regulate the EPO gene,
which, in turn enhances EPO production in vitro in an
animal model [28]. Providing vitamin A in the fortified
yoghurt may have increased the mobilization of iron from
storage [29,30], resulting in an improvement in Hb con-
centration, although the mechanism of this phenomenon
is still to be verified.
At baseline, some of the children were mild to moder-
ately deficient in iodine. The population where the study
was conducted were found to consume plain salt more
than the iodized salt, although, the national salt iodization
program of 1989 in Bangladesh is ongoing on. In our
study, iodine and RBP decreased in both the groups be-
tween base- and end-line, but the decrease was signifi-
cantly less in FY group, suggesting compliance to and
success of intervention in delivering nutrients. Similarly,
all five studies included in the systematic review also
found a beneficial effect of MMN fortification on urinary
iodine excretion levels [5].
Zinc status was less than the optimum at the baseline.
Zinc status improved but the differences in mean zinc
levels were not statistically significant and concentra-
tions were still below the accepted cutoff for the age
group at end-line (9.94 μmol/L). A review of six studies
investigated the effect of MMNs (including zinc) in forti-
fied food compared to unfortified food on zinc status,
only two studies found a significant beneficial effect [13].
While other studies, did not find any effect on biochem-
ical zinc status or deficiency [30-32]. Although dairy
products have shown to increase zinc absorption [33],
the sub-optimum effect of the zinc in the fortified yog-
hurt on zinc status could be due to the level of zinc
added being too low, to a possible negative interaction
between iron and zinc [34] or because plasma zinc may
not be a good marker of zinc status. Indeed, recent stud-
ies have shown that iron inhibits zinc absorption [35]
and vice versa. However, iron has little effect on zinc ab-
sorption when zinc-iron ratios are 1:1, which is similar
to the ratio in our study [36]. Therefore, the interaction
of iron and zinc from the fortified yoghurt should be
further investigated and the dosage of zinc should be re-
evaluated. Further, the beneficial effects on observed
height gain, which are commonly attributable to zinc
intake rather than iron [37,38] would argue for an im-
provement in zinc status which plasma zinc was not able
to reflect.
One year of fortification resulted in an improvement
in linear growth with a statistically significant change inheight velocity and height for age Z- scores, but not on
weight and BMIZ which was likely attributed to the syner-
getic effects of the micronutrients including the presence
of zinc [39]. A meta-analysis on the effects of micronu-
trients on growth in children up to 18 years of age found
that interventions with iron or vitamin A alone did not
have an effect on either height or weight gain, whereas
MMN interventions, 80% of which included vitamin A,
iron, and zinc, significantly improved linear growth and
also had a small (not statistically significant) positive effect
on weight gain [40]. These findings would suggest that
providing specific micronutrients results in a better height
gain, and reversal of growth faltering over and above of
macronutrients [26]. A systematic review that tested the
impact of multiple micronutrients provided via fortifica-
tion on the micronutrient status, growth, health, and cog-
nitive development of school children showed mixed
results i.e. no effect to a positive effect on growth. Two of
seven studies found a significant beneficial effect on height
gain, with mean differences of about 0.6 to 1.0 cm in
height increments between the groups after 6 or 14
months of intervention [5]. Finally, improvement in Hb
levels, and decline in the excretion of urinary iodine levels
and improvement in growth points towards a global im-
provement in child’s health - a functional endpoint of mul-
tiple metabolic processes. This global improvement could
be due to a combination of effects of individual constitu-
ents of the intervention and/or synergistic effects among
the components.Limitation of the study
The results of the study need to be interpreted with con-
sideration to the initial micronutrient status of the popu-
lation. The children in this study did not have severe
anemia or iron deficiency at baseline. Given the design
of the study we cannot attribute effects to a specific
component but only describe the collective impact of
the specific micronutrients tested as the experimental
intervention in this study.Conclusions
At baseline although 50% children had mild anemia, but
there was no iron deficiency in the children. The children
had normal mean RBP and iodine concentrations; how-
ever mean zinc concentrations were just below the ac-
cepted cutoff for the age group. Following 12 months of
supplementation fortification, there was no improvement
in iron status indicators; however, a significant improve-
ment in hemoglobin levels was observed. Although plasma
concentrations of iodine and RBP in both yoghurt groups
fell over the 12 month period, concentrations of these in
the FY decreased significantly less. One year of fortifica-
tion resulted in an improvement in linear growth with a
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http://www.biomedcentral.com/1471-2458/13/514statistically significant change in height gain among the
children of the FY group.
Future studies need to investigate a number of oper-
ational issues including the feasibility of distributing the
product through different channels such as schools (as
used in this study), and also through the private sector,
using a social marketing approach.
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